Tectonic Therapeutic (TECX) Accounts Payables (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Accounts Payables data on file, last reported at $2.6 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $2.6 million, down 59.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 59.16% YoY), and the FY2025 annual result was $1.1 million, up 11.99% from the prior year.
• Accounts Payables grew to $2.6 million in Q1 2026 per TECX's latest filing, from $1.1 million in the prior quarter.
• Over five years, Accounts Payables peaked at $6.3 million in Q1 2025 and troughed at $28000.0 in Q2 2022.
• A 5-year average of $1.8 million and a median of $1.1 million in 2025 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables tumbled 98.62% in 2022, then soared 3725.0% in 2023.
• A 5-year view of Accounts Payables shows it stood at $384000.0 in 2022, then grew by 6.51% to $409000.0 in 2023, then surged by 138.63% to $976000.0 in 2024, then climbed by 11.99% to $1.1 million in 2025, then surged by 133.67% to $2.6 million in 2026.
• Business Quant data shows TECX's Accounts Payables at $2.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.5 million in Q3 2025.